


To provide long term capital growth.
| Name | % Net Assets |
|---|---|
| NOVARTIS AG | 5.4% |
| ROCHE HOLDING AG PART CERT | 4.1% |
| SANOFI-AVENTIS | 4.1% |
| FRANCE TELECOM | 3.9% |
| FRESENIUS AG | 3.6% |
| ROYAL DUTCH SHELL A ORD | 3.6% |
| VIVENDI | 3.4% |
| E.ON AG | 2.8% |
| ZURICH FINANCIAL SERVICES | 2.7% |
| BAYER AG | 2.7% |
| Key | % Net Assets |
|---|---|
| 5.4% | |
| 4.1% | |
| 4.1% | |
| 3.9% | |
| 82.5% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 464.95p |
| Currency | GBP |
| Change | 2.22p |
| % | 0.48% |
| YTD change | 29.84p |
| YTD % | 6.86% |
| Fund Inception | 02/06/1986 |
|---|---|
| Fund Manager | John Botham |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.00% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.08 |
You are here: research